Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Leucapheresis in severe rheumatoid arthritis.

Literature DB >> 434945

Leucapheresis in severe rheumatoid arthritis.

J Tenenbaum, M B Urowitz, E C Keystone, I L Dwosh, J E Curtis.

Abstract

Two patients with severe seropositive rheumatoid arthritis previously unresponsive to conventional therapy have been treated with leucapheresis. This technique involves continuous cell separation daily to remove primarily lymphocytes. Clinical improvement was recorded with the use of standard rheumatological measures of inflammation. It is concluded that leucapheresis may help in the management of severely active rheumatoid arthritis when conventional therapy has been unsuccessful.

Entities: Disease Species

Mesh：

Year: 1979 PMID： 434945 PMCID： PMC1000316 DOI： 10.1136/ard.38.1.40

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

16 in total

1. Report of a three-year study on the systemic and articular indexes in rheumatoid arthritis; theoretic and clinical considerations.

Authors: J LANSBURY
Journal: Arthritis Rheum Date: 1958-12

2. The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis.

Authors: C M PLOTZ; J M SINGER
Journal: Am J Med Date: 1956-12 Impact factor: 4.965

3. Systemic lupus erythematosus and L. E. cell phenomenon.

Authors: M M HARGRAVES
Journal: Postgrad Med Date: 1954-09 Impact factor: 3.840

4. Longterm evaluation of intermittent levamisole treatment in rheumatoid arthritis.

Authors: E M Veys; H Mielants
Journal: J Rheumatol Date: 1977 Impact factor: 4.666

Review 5. Cellular immunological aspects of rheumatoid arthritis.

Authors: D T Yu; J B Peter
Journal: Semin Arthritis Rheum Date: 1974 Impact factor: 5.532

6. Effects of cyclophosphamide on B- and T-lymphocytes in rheumatoid arthritis.

Authors: P J Clements; D T Yu; J Levy; H E Paulus; E V Barnett
Journal: Arthritis Rheum Date: 1974 Jul-Aug

7. Successful management of the Sézary syndrome. Mobilization and removal of extravascular neoplastic T cells by leukapheresis.

Authors: R Edelson; M Facktor; A Andrews; M Lutzner; P Schein
Journal: N Engl J Med Date: 1974-08-08 Impact factor: 91.245

8. Azathioprine in rheumatoid arthritis. A double-blind, cross over study.

Authors: M B Urowitz; D A Gordon; H A Smythe; W Pruzanski; M A Ogryzio
Journal: Arthritis Rheum Date: 1973 May-Jun

9. Combined studies of complement receptor and surface immunoglobulin-bearing cells and sheep erythrocyte rosette-forming cells in normal and leukemic human lymphocytes.

Authors: G D Ross; E M Rabellino; M J Polley; H M Grey
Journal: J Clin Invest Date: 1973-02 Impact factor: 14.808

10. Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors: M Jondal; G Holm; H Wigzell
Journal: J Exp Med Date: 1972-08-01 Impact factor: 14.307

5 in total

Leucapheresis in severe rheumatoid arthritis.

1. Report of a three-year study on the systemic and articular indexes in rheumatoid arthritis; theoretic and clinical considerations.

2. The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis.

3. Systemic lupus erythematosus and L. E. cell phenomenon.

4. Longterm evaluation of intermittent levamisole treatment in rheumatoid arthritis.

Review 5. Cellular immunological aspects of rheumatoid arthritis.

6. Effects of cyclophosphamide on B- and T-lymphocytes in rheumatoid arthritis.

7. Successful management of the Sézary syndrome. Mobilization and removal of extravascular neoplastic T cells by leukapheresis.

8. Azathioprine in rheumatoid arthritis. A double-blind, cross over study.

9. Combined studies of complement receptor and surface immunoglobulin-bearing cells and sheep erythrocyte rosette-forming cells in normal and leukemic human lymphocytes.

10. Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

1. Where now for therapeutic apheresis?

Review 2. Twenty-five years of immunosuppression.

3. Plasmapheresis in clinical medicine.

4. Lymphapheresis as compared with rest period in treatment of severe rheumatoid arthritis.

5. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy.